Allogene Therapeutics Reports Third Quarter 2019 Financial Results

Go back to Allogene Therapeutics Reports Third Quarter 2019 Financial Results
(NASDAQ: ALLO) Delayed: 2.07 +0.02 (0.98%)
Previous Close $2.05    52 Week High
Open $2.05    52 Week Low
Day High $2.08    P/E N/A 
Day Low $2.02    EPS
Volume 204,501